Diana Landa

Diana Landa is a seasoned regulatory affairs professional with extensive experience leading regulatory strategies across various organizations in the biopharmaceutical industry. Currently, Diana serves as Vice President of Regulatory Affairs at Zai Lab, a position held since July 2025. Prior to this, Diana worked at CARGO Therapeutics and Sutro Biopharma, Inc., also in executive roles focused on regulatory affairs. Diana's tenure at Amgen included leadership as Executive Director of Global Regulatory Affairs, where responsibilities encompassed managing a global regulatory team for a diverse portfolio in oncology and inflammation. Previous positions at Teva Pharmaceuticals involved directing global regulatory strategies for innovative biologics and biosimilars. Diana holds a Bachelor of Arts degree in Chemistry and Biochemistry from La Salle University and a Master of Science degree in Regulatory Affairs/Quality Assurance from Temple University.